ROSH PINNA, Israel, November 4th, 2026, FinanceWire Peer-reviewed study published in the HCA Healthcare Journal of Medicine reports Phase 2 interim results of 90.0% sensitivity, 87.3% specificity and an AUC-ROC…

Continue Reading

ROSH PINNA, Israel, November 4th, 2026, FinanceWire Peer-reviewed study published in the HCA Healthcare Journal of Medicine reports Phase 2 interim results of 90.0% sensitivity, 87.3% specificity and an AUC-ROC…

Continue Reading
Back to top